Correlation of trisomy 12 with proliferating cells by combined immunocytochemistry and fluorescence in situ hybridization in chronic lymphocytic leukemia

Leukemia

Volumn 10, Issue 11, 1996, Pages 1705-1711

  Garcia Marco J A ^a   Price, C M ^b   Ellis, J ^a   Morey, M ^c   Matutes, E ^a   Lens, D ^a   Colman, S ^b   Catovsky, D ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

CLL; FISH; Ki 67; Trisomy 12

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 12; CHROMOSOME ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRISOMY;

EID: 0029798603     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Lelle RJ, Heidenreich W, Stauch G, Gerdes J. The correlation of growth fractions with histologic grading and lymph node status in human mammary carcinoma. Cancer 1987; 59: 83-88.
2. Hall PA, Richards MA, Gregory WM, d'Ardenne AJ, Lister TA, Stansfeld AG. The prognostic value of Ki-67 immunostaining in non-Hodgkin's lymphoma. J Pathol 1988; 154: 223-235.
3. Gerdes J, Stein H, Pileri S, Rivano MT, Gobbi M, Ralfkiaer E, Nielsen KM, Pallesen G, Bartlels H, Palestro G, Delsol G. Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas. Lancet 1987; 2: 448-449.
4. Grogan TM, Lippman SM, Spier CM, Slymen DJ, Rybski JA, Rangel CS, Richter LC, Miller TP. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood 1988; 71: 1157-1160.
5. Miller TP, Grogan TM, Dahlberg S, Spier CM, Braziel RM, Banks PM, Foucar K, Kjeldsberg CR, Levy N, Nathwani BN, Schnitzer B, Tubbs RR, Gaynor ER, Fisher RI. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group Trial. Blood 1994; 83: 1460-1466.
6. Cordone I, Matutes E, Catovsky D. Characterisation of normal peripheral blood cells in cycle identified by monoclonal antibody Ki67. J Clin Pathol 1992; 45: 201-205.
7. Gerdes J, Schawb U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with proliferation. Int J Cancer 1983; 31: 13-20.
8. Gerdes J, Lemke H, Baisch H, Wacker H, Schawb U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710-1715.
9. Cordone I, Matutes E, Catovsky D. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity. Leukemia 1992; 6: 902-906.
10. Fitchett M, Griffiths MJ, Oscier DG, Johnson S, Seabright M. Chromosome abnormalities involving band 13q14 in hematologic malignancies. Cancer Genet Cytogenet 1987; 24: 143-150.
11. Oscier DG, Fitchett M, Hamblin TJ. Chromosomal abnormalities in B-CLL. Nouv Rev Fr Hematol 1988; 30: 397-398.
12. Juliusson G, Oscier DG, Fitchett M, Ross FM, Stockdill G, Mackie MJ, Parker AC, Castoldi GL, Cuneo A, Knuutila S, Elonen E, Gharton G. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. New Engl J Med 1990; 323: 720-724.
13. Peterson L, Blackstadt M, Kay NE. Clonal evolution in chronic lymphocytic leukemia. In Cheson BD (ed). Chronic Lymphocytic Leukemia. Scientific Advances and Clinical Developments. Marcel Dekker: New York, 1993, pp 181-196.
14. Juliusson G, Gharton G, Oscier DG, Fitchett M, Ross FM, Brito-Babapulle V, Catovsky D, Knuutila S, Elonen E, Lechleitner M, Tanzer J, Schoenwald M, Castoldi GL, Cuneo A, Nowell P, Peterson L, Kay N. Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia. Second IWCCLL compilation of data on 662 patients. Leuk Lymphoma 1991; 5 (Suppl.): 21-25.
15. Matutes E, Owusu-Ankomah K, Morilla R, García-Marco J, Houlihan A, Que TH, Catovsky D. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8: 1640-1645.
16. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposal for the classification of chronic (mature) B and T lymphoid leukemias. J Clin Pathol 1989; 42: 567-584.
17. ISCN (1995). Mitelman F (ed). An International System for Human Cytogenetic Nomenclature. S Karger: Basel, 1995.
18. Que TH, García-Marco J, Ellis J, Matutes E, Brito-Babapulle V, Boyle S, Catovsky D. Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: Analysis by stage, immunophenotype and morphology. Blood 1993; 82: 571-575.
19. García-Marco J, Matutes E, Morilla R, Ellis J, Catovsky D, Price CM. Trisomy 12 in B-cell chronic lymphocytic leukemia. Assessment of lineage restriction by simultaneous analysis of immunophenotype and genotype in interphase cells by fluorescence in situ hybridization. Br J Haematol 1994; 87: 44-50.
20. Binet JL, Auquier A, Dighiero G, Cuastang C, Pignet H, Goasgnen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Gremy F. A new prognostic classification of CLL derived from a multivariate survival analysis. Cancer 1981; 48: 198-206.
21. Montserrat E, Sanchez-Bisonó J, Viñolas N, Rozman C. Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance. Br J Haematol 1986; 62: 567-575.
22. Geisler C, Philip P, Hansen M. B-cell chronic lymphocytic leukemia: clonal chromosome abnormalities and prognosis in 89 cases. Eur J Haematol 1989; 43: 397-403.
23. Vallespí T, Montserrat E, Sanz MA. Chronic lymphocytic leukaemia: prognostic value of lymphocyte morphological subtypes. A multivariate survival analysis in 146 patients. Br J Haematol 1991; 77: 478-485.
24. Del Giglio A, O'Brien S, Ford R, Saya H, Manning J, Keating M, Johnston D, Khetan R, El-Naggar A, Deisseroth A. Prognostic value of proliferating cell nuclear antigen expression in chronic lymphoid leukemia. Blood 1992; 79: 2717-2720.
25. Orfao A, Ciudad J, Gonzalez M, San Miguel JF, Garcia RA, Lopez-Berges MC, Ramos F, Del Cañizo MC, Rios A, Sanz M, Lopez Borrasca A. Prognostic value of S-phase white blood cell count in B-cell chronic lymphocytic leukemia. Leukemia 1992; 6: 47-51.
26. Raghoebier S, Kibbelaar RE, Kleiverda JK, Kluin-Nelemans JC, Van Krieken JM, Kok F, Kluin PhM. Mosaicism of trisomy 12 in chronic lymphocytic leukemia detected by non-radioactive in situ hybridization. Leukemia 1992; 6: 1220-1226.
27. Escudier SM, Pereira-Leahy JM, Drach JW, Weier HU, Goodacre AM, Cork MA, Trujillo JM, Keating MJ, Andreff M. Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia. Blood 1993; 81: 2702-2707.
28. Witzig TE, Borell TJ, Herath JF, Tefferi A, Li C-Y, Jenkins RB. Detection of trisomy 12 by FISH in untreated B-chronic lymphocytic leukemia: correlation with stage and CD20 antigen expression intensity. Leuk Lymphoma 1994; 14: 447-451.
29. Cuneo A, Wlodarska I, Sayed Aly M, Piva N, Carli MG, Fagioli F, Tallarico A, Pazzi I, Ferrari L, Cassiman JJ, Van Den Berghe H, Castoldi GL. Non-radioactive in situ hybridization for the detection and monitoring of trisomy 12 in B-cell chronic lymphocytic leukaemia. Br J Haematol 1992; 81: 192-196.
30. Criel A, Wlodarska I, Meeus P, Stul M, Louwagie A, Van Hoof A, Hidajat M, Mecucci C, Van Den Berghe H. Trisomy 12 is uncommon in typical chronic lymphocytic leukaemias. Br J Haematol 1994; 87: 523-528.
31. Döhner H, Pohl S, Bulgay-Mörschel M, Stilgenbauer S, Bentz M, Lichter P. Trisomy 12 in chronic lymphoid leukemias - a metaphase and interphase cytogenetic analysis. Leukemia 1993; 7: 516-520.
32. Anastasi J, Le Beau MM, Vardiman JW, Fernald AA, Larson RA, Rowley JD. Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method. Blood 1992; 79: 1796-1800.
33. Bird ML, Ueshima Y, Rowley JD, Haren JM, Vardiman JW. Chromosome abnormalities in B cell chronic lymphocytic leukemia and their clinical correlations. Leukemia 1989; 3: 182-191.
34. Matutes E, Oscier D, Garcia-Marco J, Ellis J, Copplestone A, Gillingham R, Hamblin T, Lens D, Swansbury GJ, Catovsky D. Trisomy 12 defines a group of CLL with atypical morphology. Correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 1996; 92: 382-388.